Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience

OBJECTIVES: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has enabled better prognosis for patients with peritoneal surface malignancies. However, in older age groups, short -and long-term outcomes are still perceived as poor. We evaluated patients aged 70 and over...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ernest, Shamavonian, Raphael, Mui, Jasmine, Hayler, Raymond, Karpes, Josh, Wijayawardana, Ruwanthi, Barat, Shoma, Ahmadi, Nima, Morris, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249755/
https://www.ncbi.nlm.nih.gov/pubmed/37304160
http://dx.doi.org/10.1515/pp-2022-0202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249755/
https://www.ncbi.nlm.nih.gov/pubmed/37304160
http://dx.doi.org/10.1515/pp-2022-0202

Ejemplares similares